TrialLeukemia2023
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trial.
Kyoo-Hyung Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it